G3BP1 Maintains Vascular Endothelial Barrier Integrity by Negatively Regulating the MYD88-ARNO-ARF6 Signaling Pathway

Endothelial permeability is essential for vascular function. This process is regulated by intercellular junctions, including adherens junctions (AJs) and tight junctions (TJs), which form the endothelial barrier and dynamically connect adjacent cells. However, the mechanisms that control endothelial permeability are not fully understood. We investigated the role of the RNA-binding protein G3BP1 in regulating endothelial permeability. We examined the effects of Loss of g3bp1 in conditional knockout mice and primary human HUVEC cells. We analyzed endothelial barrier integrity and permeability, focusing on AJ and TJ expression, under both normal and LPS-induced inflammatory conditions. Loss of g3bp1 in vascular endothelial cells decreased AJ and TJ expression, compromised barrier integrity, and increased permeability. These effects were exacerbated under LPS-induced inflammatory conditions. Loss of g3bp1 also increased the expression of MYD88, ARNO, and ARF6, and enhanced ARF6 activity. Mechanistically, G3BP1 bound to and stabilized MYD88 mRNA, negatively regulating the MYD88-ARNO-ARF6 signaling pathway. Inhibiting this pathway by reducing MYD88 or ARF6 expression, or inhibiting ARNO activity, restored AJ/TJ expression and barrier function in G3BP1-deficient models. Our findings identify G3BP1 as a novel regulator of vascular endothelial permeability. G3BP1 acts by negatively regulating the MYD88-ARNO-ARF6 signaling pathway. Targeting G3BP1 may be a potential therapeutic strategy for diseases associated with endothelial barrier dysfunction.